CS logo
small CS logo
Instituto de Ciencias Médicas

Alicante, Spain
Research institute in Alicante
C. Poeta Quintana, 56, 03004 Alicante

About Instituto de Ciencias Médicas


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
8
Pfizer
3
Boehringer Ingelheim
1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.
1
Hoffmann-La Roche
1
Total Rows: 5

Clinical Trials at Instituto de Ciencias Médicas


During the past decade, Instituto de Ciencias Médicas conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 10 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11220066330000001111Started TrialsCompleted Trails2015201620172018201902468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto de Ciencias Médicas" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 3 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Ciencias Médicas" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 8Eli Lilly and Company: 8Pfizer: 3Pfizer: 3Boehringer Ingelheim: 1Boehringer Ingelheim: 1GB001, Inc, a whollyowned subsidiary ofGossamer Bio, Inc.: 1GB001, Inc, a whollyowned subsidiary ofGossamer Bio, Inc.: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 4Eli Lilly and Company: 4

Clinical Trials Conditions at Instituto de Ciencias Médicas


According to Clinical.Site data, the most researched conditions in "Instituto de Ciencias Médicas" are "Ulcerative Colitis" (3 trials), "Asthma" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Instituto de Ciencias Médicas" in a lesser frequency.

Clinical Trials Intervention Types at Instituto de Ciencias Médicas


Most popular intervention types in "Instituto de Ciencias Médicas" are "Drug" (13 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Mirikizumab" (3 trials), "Tirzepatide" (3 trials), "Dulaglutide" (1 trials) and "GB001" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto de Ciencias Médicas


The vast majority of trials in "Instituto de Ciencias Médicas" are 14 trials for "All" genders.

Clinical Trials Status at Instituto de Ciencias Médicas


Currently, there are NaN active trials in "Instituto de Ciencias Médicas". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Instituto de Ciencias Médicas, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Ciencias Médicas, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 2Phase 2: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 3Active, not recruiting: 3Recruiting: 2Recruiting: 2